76 related articles for article (PubMed ID: 6321670)
1. Serum cyclophosphamide activity in patients treated for small cell carcinoma of the lung.
Sarpel SC; Lad T; Epstein RB
J Clin Oncol; 1983 Jan; 1(1):29-32. PubMed ID: 6321670
[TBL] [Abstract][Full Text] [Related]
2. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer].
Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM
Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593
[TBL] [Abstract][Full Text] [Related]
3. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
[TBL] [Abstract][Full Text] [Related]
4. Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung.
Abrams RA; Johnston-Early A; Kramer C; Minna JD; Cohen MH; Deisseroth AB
Cancer Res; 1981 Jan; 41(1):35-41. PubMed ID: 6256063
[TBL] [Abstract][Full Text] [Related]
5. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
[TBL] [Abstract][Full Text] [Related]
6. The effect of cancer and chemotherapy on monocyte function.
Lower EE; Baughman RP
J Clin Lab Immunol; 1990 Mar; 31(3):121-5. PubMed ID: 1966996
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between the number of monocytes and granulocytes in the peripheral blood in lung cancer patients].
Sukhanov IuS
Probl Gematol Pereliv Krovi; 1976 Dec; 21(12):23-6. PubMed ID: 1024199
[No Abstract] [Full Text] [Related]
8. [The effect of lithium carbonate against leukopenia during systemic chemotherapy in patients with small cell carcinoma of the lung].
Tamura S; Fujikura M; Takahashi S; Maebo A; Nakano T; Yamada W; Fujii J; Nabeshima K; Hada T; Higashino K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2338-44. PubMed ID: 3000298
[TBL] [Abstract][Full Text] [Related]
9. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
Holoye PY
Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of Ca(2+)-induced response of erythrocytes in patients with lung cancer during antineoplastic chemotherapy].
Petrova IV; Stepovaia EA; Sokolova IB; Gol'dberg VE; Chasovskikh NIu; Koreshkova KG; Bazhenova NG; Kolosova MV; Baskakov MB; Novitskiĭ VV; Medvedev MA
Biull Eksp Biol Med; 1997 Aug; 124(8):195-8. PubMed ID: 9410209
[No Abstract] [Full Text] [Related]
11. [Radioimmunologic evaluation of the prognosis and effective therapy of patients with small cell lung cancer].
Ausekar BP6 ; Smirnova KD; Gromova NV; Perevodchikova NI
Med Radiol (Mosk); 1985 Nov; 30(11):18-20. PubMed ID: 2999553
[TBL] [Abstract][Full Text] [Related]
12. The importance of dose and dose intensity in lung cancer chemotherapy.
Murray N
Semin Oncol; 1987 Dec; 14(4 Suppl 4):20-8. PubMed ID: 2825357
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
Padjas A; Lesisz D; Lankoff A; Banasik A; Lisowska H; Bakalarz R; Góźdź S; Wojcik A
Toxicol Appl Pharmacol; 2005 Dec; 209(2):183-91. PubMed ID: 15885733
[TBL] [Abstract][Full Text] [Related]
14. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
[No Abstract] [Full Text] [Related]
15. Pretreatment serum albumin concentration and lactic dehydrogenase activity as prognostic factors in patients with small cell lung cancer.
Ohnoshi T; Hiraki S; Nakata Y; Ozawa S; Tamura T; Seto T; Miyai M; Kawahara S; Numata T; Kimura I
Acta Med Okayama; 1982 Dec; 36(6):487-90. PubMed ID: 6297259
[TBL] [Abstract][Full Text] [Related]
16. Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.
Ardizzoni A; Tjan-Heijnen VC; Postmus PE; Buchholz E; Biesma B; Karnicka-Mlodkowska H; Dziadziuszko R; Burghouts J; Van Meerbeeck JP; Gans S; Legrand C; Debruyne C; Giaccone G; Manegold C;
J Clin Oncol; 2002 Oct; 20(19):3947-55. PubMed ID: 12351591
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy.
Ihde DC; Makuch RW; Carney DN; Bunn PA; Cohen MH; Matthews MJ; Minna JD
Am Rev Respir Dis; 1981 May; 123(5):500-7. PubMed ID: 6263137
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E
Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for lung cancer.
Perevodchikova NI
Cancer Treat Rep; 1976 Oct; 60(10):1479-81. PubMed ID: 191187
[No Abstract] [Full Text] [Related]
20. [The role of chemotherapy in the palliative and curative treatment of lung cancer (author's transl)].
Kenis Y; Rozencweig M
Acta Tuberc Pneumol Belg; 1975; 66(4-5):368-79. PubMed ID: 178163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
